NCT02177721 Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario Status NOT_YET_RECRUITING Phase PHASE4
NCT02055183 BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin Status COMPLETED Phase N/A